STAG2_HUMAN - dbPTM
STAG2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID STAG2_HUMAN
UniProt AC Q8N3U4
Protein Name Cohesin subunit SA-2
Gene Name STAG2
Organism Homo sapiens (Human).
Sequence Length 1231
Subcellular Localization Nucleus. Chromosome. Chromosome, centromere. Associates with chromatin. Before prophase it is scattered along chromosome arms. During prophase, most of cohesin complexes dissociate from chromatin probably because of phosphorylation by PLK1, except at
Protein Description Component of cohesin complex, a complex required for the cohesion of sister chromatids after DNA replication. The cohesin complex apparently forms a large proteinaceous ring within which sister chromatids can be trapped. At anaphase, the complex is cleaved and dissociates from chromatin, allowing sister chromatids to segregate. The cohesin complex may also play a role in spindle pole assembly during mitosis..
Protein Sequence MIAAPEIPTDFNLLQESETHFSSDTDFEDIEGKNQKQGKGKTCKKGKKGPAEKGKGGNGGGKPPSGPNRMNGHHQQNGVENMMLFEVVKMGKSAMQSVVDDWIESYKHDRDIALLDLINFFIQCSGCKGVVTAEMFRHMQNSEIIRKMTEEFDEDSGDYPLTMAGPQWKKFKSSFCEFIGVLVRQCQYSIIYDEYMMDTVISLLTGLSDSQVRAFRHTSTLAAMKLMTALVNVALNLSINMDNTQRQYEAERNKMIGKRANERLELLLQKRKELQENQDEIENMMNAIFKGVFVHRYRDAIAEIRAICIEEIGIWMKMYSDAFLNDSYLKYVGWTMHDKQGEVRLKCLTALQGLYYNKELNSKLELFTSRFKDRIVSMTLDKEYDVAVQAIKLLTLVLQSSEEVLTAEDCENVYHLVYSAHRPVAVAAGEFLYKKLFSRRDPEEDGMMKRRGRQGPNANLVKTLVFFFLESELHEHAAYLVDSMWDCATELLKDWECMNSLLLEEPLSGEEALTDRQESALIEIMLCTIRQAAECHPPVGRGTGKRVLTAKEKKTQLDDRTKITELFAVALPQLLAKYSVDAEKVTNLLQLPQYFDLEIYTTGRLEKHLDALLRQIRNIVEKHTDTDVLEACSKTYHALCNEEFTIFNRVDISRSQLIDELADKFNRLLEDFLQEGEEPDEDDAYQVLSTLKRITAFHNAHDLSKWDLFACNYKLLKTGIENGDMPEQIVIHALQCTHYVILWQLAKITESSSTKEDLLRLKKQMRVFCQICQHYLTNVNTTVKEQAFTILCDILMIFSHQIMSGGRDMLEPLVYTPDSSLQSELLSFILDHVFIEQDDDNNSADGQQEDEASKIEALHKRRNLLAAFCKLIVYTVVEMNTAADIFKQYMKYYNDYGDIIKETMSKTRQIDKIQCAKTLILSLQQLFNEMIQENGYNFDRSSSTFSGIKELARRFALTFGLDQLKTREAIAMLHKDGIEFAFKEPNPQGESHPPLNLAFLDILSEFSSKLLRQDKRTVYVYLEKFMTFQMSLRREDVWLPLMSYRNSLLAGGDDDTMSVISGISSRGSTVRSKKSKPSTGKRKVVEGMQLSLTEESSSSDSMWLSREQTLHTPVMMQTPQLTSTIMREPKRLRPEDSFMSVYPMQTEHHQTPLDYNRRGTSLMEDDEEPIVEDVMMSSEGRIEDLNEGMDFDTMDIDLPPSKNRRERTELKPDFFDPASIMDESVLGVSMF
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MIAAPEIP
-------CCCCCCCC
22.9320068231
9PhosphorylationIAAPEIPTDFNLLQE
CCCCCCCCCCCHHHH
59.9130108239
17PhosphorylationDFNLLQESETHFSSD
CCCHHHHCCCCCCCC
34.5330108239
19PhosphorylationNLLQESETHFSSDTD
CHHHHCCCCCCCCCC
37.1830108239
22PhosphorylationQESETHFSSDTDFED
HHCCCCCCCCCCHHH
21.5030108239
23PhosphorylationESETHFSSDTDFEDI
HCCCCCCCCCCHHHC
43.5225159151
25PhosphorylationETHFSSDTDFEDIEG
CCCCCCCCCHHHCCC
44.5330108239
48AcetylationKTCKKGKKGPAEKGK
CCCCCCCCCCCCCCC
77.9626051181
53AcetylationGKKGPAEKGKGGNGG
CCCCCCCCCCCCCCC
68.9426051181
55AcetylationKGPAEKGKGGNGGGK
CCCCCCCCCCCCCCC
74.7826051181
62AcetylationKGGNGGGKPPSGPNR
CCCCCCCCCCCCCCC
57.9625953088
132PhosphorylationSGCKGVVTAEMFRHM
CCCCCHHHHHHHHHH
17.9421406692
142PhosphorylationMFRHMQNSEIIRKMT
HHHHHCCHHHHHHHH
17.1820068231
149PhosphorylationSEIIRKMTEEFDEDS
HHHHHHHHHHHCCCC
35.08-
156PhosphorylationTEEFDEDSGDYPLTM
HHHHCCCCCCCCCCC
31.36-
159PhosphorylationFDEDSGDYPLTMAGP
HCCCCCCCCCCCCCH
12.03-
162PhosphorylationDSGDYPLTMAGPQWK
CCCCCCCCCCCHHHH
10.64-
169UbiquitinationTMAGPQWKKFKSSFC
CCCCHHHHHHHHHHH
42.98-
173PhosphorylationPQWKKFKSSFCEFIG
HHHHHHHHHHHHHHH
31.60-
174PhosphorylationQWKKFKSSFCEFIGV
HHHHHHHHHHHHHHH
34.21-
270AcetylationRLELLLQKRKELQEN
HHHHHHHHHHHHHHC
66.4625953088
270UbiquitinationRLELLLQKRKELQEN
HHHHHHHHHHHHHHC
66.4621890473
272UbiquitinationELLLQKRKELQENQD
HHHHHHHHHHHHCHH
70.57-
358UbiquitinationLQGLYYNKELNSKLE
HHHHHHCHHHHHHHH
47.67-
362PhosphorylationYYNKELNSKLELFTS
HHCHHHHHHHHHHHH
51.7722210691
363UbiquitinationYNKELNSKLELFTSR
HCHHHHHHHHHHHHH
44.9321890473
363UbiquitinationYNKELNSKLELFTSR
HCHHHHHHHHHHHHH
44.9321890473
363UbiquitinationYNKELNSKLELFTSR
HCHHHHHHHHHHHHH
44.9321890473
363 (in isoform 2)Ubiquitination-44.93-
377PhosphorylationRFKDRIVSMTLDKEY
HHHHHHHHCCCCCCH
12.0430576142
379PhosphorylationKDRIVSMTLDKEYDV
HHHHHHCCCCCCHHH
25.0530576142
433PhosphorylationVAAGEFLYKKLFSRR
HHHHHHHHHHHHCCC
16.0525884760
449UbiquitinationPEEDGMMKRRGRQGP
HHHCCHHHCCCCCCC
30.01-
449 (in isoform 2)Ubiquitination-30.01-
528PhosphorylationLIEIMLCTIRQAAEC
HHHHHHHHHHHHHHC
18.4224043423
551AcetylationGKRVLTAKEKKTQLD
CCCCCCHHHHCCCCC
65.9025953088
562UbiquitinationTQLDDRTKITELFAV
CCCCCCHHHHHHHHH
48.82-
562 (in isoform 2)Ubiquitination-48.82-
602PhosphorylationFDLEIYTTGRLEKHL
ECEEEEECCCHHHHH
11.88-
607UbiquitinationYTTGRLEKHLDALLR
EECCCHHHHHHHHHH
54.8021890473
607UbiquitinationYTTGRLEKHLDALLR
EECCCHHHHHHHHHH
54.8021890473
607AcetylationYTTGRLEKHLDALLR
EECCCHHHHHHHHHH
54.8019608861
607UbiquitinationYTTGRLEKHLDALLR
EECCCHHHHHHHHHH
54.8019608861
622AcetylationQIRNIVEKHTDTDVL
HHHHHHHHCCCHHHH
40.6925953088
622UbiquitinationQIRNIVEKHTDTDVL
HHHHHHHHCCCHHHH
40.69-
622 (in isoform 2)Ubiquitination-40.69-
634UbiquitinationDVLEACSKTYHALCN
HHHHHHHHHHHHHHC
53.65-
664UbiquitinationLIDELADKFNRLLED
HHHHHHHHHHHHHHH
38.6421890473
664UbiquitinationLIDELADKFNRLLED
HHHHHHHHHHHHHHH
38.6421890473
664AcetylationLIDELADKFNRLLED
HHHHHHHHHHHHHHH
38.6426051181
664UbiquitinationLIDELADKFNRLLED
HHHHHHHHHHHHHHH
38.6421890473
664 (in isoform 2)Ubiquitination-38.64-
685PhosphorylationEPDEDDAYQVLSTLK
CCCCCHHHHHHHHHH
13.22-
692UbiquitinationYQVLSTLKRITAFHN
HHHHHHHHHHHHCCC
41.6721906983
705UbiquitinationHNAHDLSKWDLFACN
CCCCCCHHHCHHHHC
52.61-
705 (in isoform 2)Ubiquitination-52.61-
714AcetylationDLFACNYKLLKTGIE
CHHHHCHHHHHHCHH
33.0926051181
714UbiquitinationDLFACNYKLLKTGIE
CHHHHCHHHHHHCHH
33.09-
714 (in isoform 2)Ubiquitination-33.09-
737PhosphorylationVIHALQCTHYVILWQ
HHHHHHHCHHHHHHH
11.8622067460
749PhosphorylationLWQLAKITESSSTKE
HHHHHHHHCCCCCHH
29.1621406692
751PhosphorylationQLAKITESSSTKEDL
HHHHHHCCCCCHHHH
22.4221406692
752PhosphorylationLAKITESSSTKEDLL
HHHHHCCCCCHHHHH
35.4821406692
753PhosphorylationAKITESSSTKEDLLR
HHHHCCCCCHHHHHH
53.4221406692
754PhosphorylationKITESSSTKEDLLRL
HHHCCCCCHHHHHHH
40.1621406692
755AcetylationITESSSTKEDLLRLK
HHCCCCCHHHHHHHH
51.7026051181
755UbiquitinationITESSSTKEDLLRLK
HHCCCCCHHHHHHHH
51.7021906983
755 (in isoform 2)Ubiquitination-51.70-
843PhosphorylationEQDDDNNSADGQQED
ECCCCCCCCCCCCCC
33.7120363803
860UbiquitinationSKIEALHKRRNLLAA
HHHHHHHHHHHHHHH
54.63-
874PhosphorylationAFCKLIVYTVVEMNT
HHHHHHHHHHHHHCC
6.1928270605
875PhosphorylationFCKLIVYTVVEMNTA
HHHHHHHHHHHHCCH
13.7428270605
881PhosphorylationYTVVEMNTAADIFKQ
HHHHHHCCHHHHHHH
23.1628270605
889PhosphorylationAADIFKQYMKYYNDY
HHHHHHHHHHHHCHH
9.00-
891UbiquitinationDIFKQYMKYYNDYGD
HHHHHHHHHHCHHHH
39.38-
892PhosphorylationIFKQYMKYYNDYGDI
HHHHHHHHHCHHHHH
7.3218083107
893PhosphorylationFKQYMKYYNDYGDII
HHHHHHHHCHHHHHH
8.9518083107
896PhosphorylationYMKYYNDYGDIIKET
HHHHHCHHHHHHHHH
17.0422817900
901AcetylationNDYGDIIKETMSKTR
CHHHHHHHHHHHHCC
47.6826051181
901UbiquitinationNDYGDIIKETMSKTR
CHHHHHHHHHHHHCC
47.68-
901 (in isoform 2)Ubiquitination-47.68-
903PhosphorylationYGDIIKETMSKTRQI
HHHHHHHHHHHCCCC
23.0329759185
905PhosphorylationDIIKETMSKTRQIDK
HHHHHHHHHCCCCCH
37.9929759185
912AcetylationSKTRQIDKIQCAKTL
HHCCCCCHHHHHHHH
35.9825953088
912UbiquitinationSKTRQIDKIQCAKTL
HHCCCCCHHHHHHHH
35.98-
941PhosphorylationNGYNFDRSSSTFSGI
CCCCCCCCCCCCHHH
30.4121406692
942PhosphorylationGYNFDRSSSTFSGIK
CCCCCCCCCCCHHHH
34.0021406692
943PhosphorylationYNFDRSSSTFSGIKE
CCCCCCCCCCHHHHH
34.4221406692
944PhosphorylationNFDRSSSTFSGIKEL
CCCCCCCCCHHHHHH
24.6221406692
946PhosphorylationDRSSSTFSGIKELAR
CCCCCCCHHHHHHHH
39.4321406692
949AcetylationSSTFSGIKELARRFA
CCCCHHHHHHHHHHH
50.6426051181
949UbiquitinationSSTFSGIKELARRFA
CCCCHHHHHHHHHHH
50.64-
949 (in isoform 2)Ubiquitination-50.64-
965UbiquitinationTFGLDQLKTREAIAM
HHCHHHHHHHHHHHH
39.6421890473
965UbiquitinationTFGLDQLKTREAIAM
HHCHHHHHHHHHHHH
39.6421890473
965UbiquitinationTFGLDQLKTREAIAM
HHCHHHHHHHHHHHH
39.642189047
965 (in isoform 2)Ubiquitination-39.64-
1017PhosphorylationLLRQDKRTVYVYLEK
HHCCCCCHHEEEHHH
23.1722210691
1019PhosphorylationRQDKRTVYVYLEKFM
CCCCCHHEEEHHHHH
5.2428152594
1021PhosphorylationDKRTVYVYLEKFMTF
CCCHHEEEHHHHHHH
7.4622210691
1047PhosphorylationPLMSYRNSLLAGGDD
HHHHHCCCHHCCCCC
18.7625262027
1056PhosphorylationLAGGDDDTMSVISGI
HCCCCCCHHHHHHHC
20.5230266825
1057SulfoxidationAGGDDDTMSVISGIS
CCCCCCHHHHHHHCC
3.7621406390
1058PhosphorylationGGDDDTMSVISGISS
CCCCCHHHHHHHCCC
20.5622167270
1061PhosphorylationDDTMSVISGISSRGS
CCHHHHHHHCCCCCC
28.1122167270
1064PhosphorylationMSVISGISSRGSTVR
HHHHHHCCCCCCCCC
19.9422167270
1065PhosphorylationSVISGISSRGSTVRS
HHHHHCCCCCCCCCC
38.4522167270
1066MethylationVISGISSRGSTVRSK
HHHHCCCCCCCCCCC
35.975172523
1068PhosphorylationSGISSRGSTVRSKKS
HHCCCCCCCCCCCCC
23.7123090842
1069PhosphorylationGISSRGSTVRSKKSK
HCCCCCCCCCCCCCC
23.8223090842
1071MethylationSSRGSTVRSKKSKPS
CCCCCCCCCCCCCCC
42.73115387683
1075PhosphorylationSTVRSKKSKPSTGKR
CCCCCCCCCCCCCCC
54.2423898821
1078PhosphorylationRSKKSKPSTGKRKVV
CCCCCCCCCCCCCCE
54.2323898821
1079PhosphorylationSKKSKPSTGKRKVVE
CCCCCCCCCCCCCEE
56.0723898821
1091PhosphorylationVVEGMQLSLTEESSS
CEECEEEEECCCCCC
19.1627251275
1093PhosphorylationEGMQLSLTEESSSSD
ECEEEEECCCCCCCC
34.0427251275
1096PhosphorylationQLSLTEESSSSDSMW
EEEECCCCCCCCCCC
29.3227251275
1097PhosphorylationLSLTEESSSSDSMWL
EEECCCCCCCCCCCC
36.8227690223
1099PhosphorylationLTEESSSSDSMWLSR
ECCCCCCCCCCCCCH
35.3421601212
1105PhosphorylationSSDSMWLSREQTLHT
CCCCCCCCHHHHCCC
20.4726074081
1109PhosphorylationMWLSREQTLHTPVMM
CCCCHHHHCCCCCCC
18.7630266825
1112PhosphorylationSREQTLHTPVMMQTP
CHHHHCCCCCCCCCC
22.2330266825
1118PhosphorylationHTPVMMQTPQLTSTI
CCCCCCCCCCCHHHH
8.6325159151
1122PhosphorylationMMQTPQLTSTIMREP
CCCCCCCHHHHHCCC
20.6929978859
1123PhosphorylationMQTPQLTSTIMREPK
CCCCCCHHHHHCCCC
25.2429978859
1124PhosphorylationQTPQLTSTIMREPKR
CCCCCHHHHHCCCCC
17.3529978859
1137PhosphorylationKRLRPEDSFMSVYPM
CCCCCCCCCCCCCCC
22.6126552605
1140PhosphorylationRPEDSFMSVYPMQTE
CCCCCCCCCCCCCCC
19.2526552605
1142PhosphorylationEDSFMSVYPMQTEHH
CCCCCCCCCCCCCCC
5.9126552605
1146PhosphorylationMSVYPMQTEHHQTPL
CCCCCCCCCCCCCCC
30.9126552605
1151PhosphorylationMQTEHHQTPLDYNRR
CCCCCCCCCCCCCCC
22.8225159151
1155PhosphorylationHHQTPLDYNRRGTSL
CCCCCCCCCCCCCCC
20.4626552605
1158MethylationTPLDYNRRGTSLMED
CCCCCCCCCCCCCCC
49.45115917913
1160PhosphorylationLDYNRRGTSLMEDDE
CCCCCCCCCCCCCCC
19.5123401153
1161PhosphorylationDYNRRGTSLMEDDEE
CCCCCCCCCCCCCCC
28.6630266825
1177PhosphorylationIVEDVMMSSEGRIED
HHHHHHHCCCCCHHH
13.7225159151
1178PhosphorylationVEDVMMSSEGRIEDL
HHHHHHCCCCCHHHC
26.6121712546
1181 (in isoform 2)Phosphorylation-25.6829116813
1193PhosphorylationNEGMDFDTMDIDLPP
CCCCCCCCCCCCCCC
19.4115737063
1197 (in isoform 2)Phosphorylation-49.1929116813
1198PhosphorylationFDTMDIDLPPSKNRR
CCCCCCCCCCCCCHH
7.4027251275
1198 (in isoform 2)Phosphorylation-7.4029116813
1219PhosphorylationPDFFDPASIMDESVL
CCCCCHHHHCCHHHH
24.6726270265
1224PhosphorylationPASIMDESVLGVSMF
HHHHCCHHHHCCCCC
20.5515737063
1229PhosphorylationDESVLGVSMF-----
CHHHHCCCCC-----
16.81-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of STAG2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of STAG2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of STAG2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SSU72_HUMANSSU72physical
20818333
RAD21_HUMANRAD21physical
17113138
SMC1A_HUMANSMC1Aphysical
17113138
SMC3_HUMANSMC3physical
17113138
PDS5A_HUMANPDS5Aphysical
17113138
PDS5B_HUMANPDS5Bphysical
17113138
RAD21_HUMANRAD21physical
17962804
SMC3_HUMANSMC3physical
17962804
SMC1A_HUMANSMC1Aphysical
10931856
SMC3_HUMANSMC3physical
10931856
RAD21_HUMANRAD21physical
10931856
BZW2_HUMANBZW2physical
26344197
COPE_HUMANCOPEphysical
26344197
EXOS2_HUMANEXOSC2physical
26344197
EXOS9_HUMANEXOSC9physical
26344197
PDS5A_HUMANPDS5Aphysical
26344197
RAD21_HUMANRAD21physical
26344197
SMC1A_HUMANSMC1Aphysical
26344197
SMC1B_HUMANSMC1Bphysical
26344197
SMC3_HUMANSMC3physical
26344197
WAPL_HUMANWAPALphysical
17113138

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of STAG2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-607, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1058; SER-1061 ANDTHR-1112, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1058; SER-1061 ANDSER-1065, AND MASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1061, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1061, AND MASSSPECTROMETRY.

TOP